What is the current direct consumer genetic testing market size?

The direct consumer genetic testing market size was valued at USD 1.2 billion in 2023, driven by rising health awareness and personalized medicine demand.

What is the expected growth rate for this market?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in genomic technologies and expanding consumer adoption.

What are the key drivers of this industry?

Key drivers include increased health consciousness, declining DNA sequencing costs, and the popularity of ancestry and wellness insights among consumers.

What challenges does the market face?

Challenges include regulatory scrutiny, data privacy concerns, and limited consumer understanding of genetic test results and their implications.

Which regions lead the direct consumer genetic testing market?

North America dominates due to high healthcare expenditure, followed by Europe and the Asia-Pacific region, particularly in China and India.

Who are the top companies in this sector?

Leading companies include 23andMe, AncestryDNA, MyHeritage, and FamilyTreeDNA, which leverage brand recognition and extensive consumer databases.

What future opportunities exist for market players?

Opportunities lie in expanding into emerging markets, integrating AI for deeper data analysis, and offering pharmacogenomics-based health solutions.

How is technology impacting this market?

Advancements in next-generation sequencing (NGS) and artificial intelligence are enhancing test accuracy, reducing costs, and enabling broader consumer applications.

What is the regulatory landscape like?

Regulators like the FDA in the U.S. and GDPR in the EU enforce strict data security and validation standards, shaping product compliance and consumer trust.

direct consumer genetic testing Market: Opportunity by 2034 | In-Depth Report

direct consumer genetic testing by Production Analysis, by Consumption Analysis, by Import Market Analysis (Value & Volume), by Export Market Analysis (Value & Volume), by Price Trend Analysis Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

direct consumer genetic testing Market Size | CAGR 18.5 Forecast 2033

direct consumer genetic testing Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

direct consumer genetic testing Market Overview

The direct consumer genetic testing market encompasses at-home DNA testing services provided directly to individuals, offering insights into ancestry, health predispositions, and wellness traits. This industry holds strategic relevance in the life sciences sector, driven by rising consumer interest in personalized health and ancestry exploration. The direct consumer genetic testing market size reached $2.1 billion in 2023, with a growth outlook projecting robust expansion through 2033. Key industry expansion drivers include advancements in genomic sequencing technologies, increased digital health adoption, and growing consumer demand for proactive health management.

The market is forecasted to grow at a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033, fueled by macroeconomic tailwinds such as healthcare digitization and rising obesity-related disease prevalence. Technology shifts like AI-driven data analytics and non-invasive sample collection methods are reshaping service delivery, while regulatory frameworks around data privacy and test accuracy remain critical compliance considerations. North America dominates the market due to established DTC players and high consumer tech literacy, whereas the Asia-Pacific region is the fastest-growing due to rising middle-class disposable incomes and expanding biotech ecosystems.

Loading chart…

Analysis: The segment-stacked chart illustrates the evolving value distribution across core services. Ancestry testing remains the largest segment, reflecting strong consumer curiosity about heritage. Health & wellness testing is the fastest-growing, underpinned by partnerships with healthcare providers and insurance companies. Pharmacogenomics, while still nascent, is gaining traction as personalized medication regimens become more mainstream. Regional disparities in adoption rates and regulatory environments further underscore the need for localized strategies.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	8.94 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	23andMe; MyHeritage; Ancestry.com; LabCorp; Myriad Genetics; Quest Diagnostics; Gene By Gene; DNA Diagnostics Center; Invitae; IntelliGenetics; Ambry Genetics; Living DNA; EasyDNA; Pathway Genomics; Centrillion Technology; Xcode; Color Genomics; Anglia DNA Services; African Ancestry; Canadian DNA Services; DNA Family Check; Alpha Biolaboratories; Test Me DNA; 23 Mofang; Genetic Health; DNA Services of America; Shuwen Health Sciences; Mapmygenome; Full Genomes
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for personalized healthcare is accelerating adoption, as consumers seek actionable insights for preventive care and wellness optimization.

Advancements in AI-driven genomic analytics are improving test accuracy and expanding use cases, such as pharmacogenomic profiling, which enhances the direct consumer genetic testing market size growth forecast.

Restraints2 items

Stringent regulatory frameworks in key regions, such as the EU’s General Data Protection Regulation (GDPR), increase compliance costs and delay product launches.

Consumer skepticism about data privacy and potential misuse of genetic information hampers market penetration, despite growing demand.

Opportunities2 items

Expansion into emerging markets with improving healthcare infrastructure, such as India and Southeast Asia, offers untapped potential for direct consumer genetic testing market players.

Integration with digital health ecosystems, including telemedicine and wearable devices, creates synergies for holistic health monitoring services.

Challenges2 items

Intense competition drives price erosion, pressuring profit margins for firms offering commoditized ancestry or basic health screening tests.

Fragmented reimbursement policies and lack of standardized clinical validation protocols hinder broader acceptance in medical communities.

Market Segmentation

Loading chart…

Direct consumer genetic testing segmentation by test type includes autosomal DNA, Y-chromosome (Y-DNA), and mitochondrial DNA (mtDNA) analyses. Autosomal DNA tests dominate the market, accounting for ~65% of volume, due to their broad application in ancestry and trait analysis. Y-DNA tests, comprising ~25%, cater to male-specific lineage tracing, while mtDNA tests (~10%) focus on maternal ancestry. This segmentation drives revenue through test complexity and consumer demand for specific heritage insights.

Direct consumer genetic testing market taxonomy by application reveals three key categories: ancestry/heritage, health/medical, and personal insights. Ancestry testing (45% of market share) remains the largest segment, driven by consumer interest in genealogy. Health/medical applications (35%) include carrier screening and disease risk assessments, fueled by rising genomic literacy. Personal insights (20%), such as trait and nutrition profiling, attract niche demand, balancing the market’s growth trajectory.

Direct consumer genetic testing segmentation by end-user includes individual consumers and family groups. Individual users (~70% of market activity) prioritize personal health or ancestry queries, while family groups (~30%) drive bulk purchases for genealogical mapping. This distinction impacts product pricing strategies and marketing focus, with family packages offering discounts to encourage multi-sample testing. The segment composition reflects the market’s dual emphasis on personalization and collective heritage exploration.

Regional Insights

Loading chart…

North America dominates the direct consumer genetic testing market growth, accounting for 42% of the global share, driven by a mature ecosystem, high consumer adoption, and supportive regulatory frameworks. The region benefits from strong digital infrastructure, early market entrants, and a culture of health-conscious consumers. Europe follows with 30%, fueled by robust healthcare investments, increasing awareness of personalized medicine, and favorable policies in countries like the UK and Germany. However, stringent data privacy regulations may moderate growth.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 18% through 2030, supported by rising middle-class populations, improving internet penetration, and partnerships between local firms and global players. Japan and India lead adoption due to tech-savvy demographics and government-backed healthcare digitization initiatives. Latin America (5%) and the Middle East & Africa (3%) remain nascent, constrained by lower digital infrastructure maturity but showing potential as mobile-first ecosystems expand.

Key Drivers by Region5 items

North America: Ecosystem maturity, regulatory clarity, and high consumer spending power

Europe: Harmonized regulatory environment, public-private partnerships, and aging population demand

Asia Pacific: Demographic shifts, mobile-first adoption, and government health-tech investments

Latin America: Rising disposable income and mobile health platforms

Middle East & Africa: Policy reforms to attract biotech investments and digital payment infrastructure

Competitive Landscape

The direct consumer genetic testing competitive landscape is moderately consolidated, with global players and regional firms vying for market share. Key players differentiate through pricing models (e.g., subscription-based vs. one-time tests), regulatory compliance (CE-IVD, CLIA), and product portfolios (health insights, ancestry, pharmacogenomics). Distribution channels—direct-to-consumer, pharmacy partnerships, and physician referrals—remain critical, alongside investments in AI-driven analytics and data privacy frameworks. Regional players target niche segments (e.g., African Ancestry for heritage tracking), while global firms prioritize broad genomic coverage.

Strategies include vertical integration (e.g., LabCorp linking testing with healthcare services), strategic acquisitions (e.g., Quest Diagnostics expanding into digital health), and R&D partnerships for technology validation. Differentiation hinges on proprietary testing algorithms (e.g., Invitae’s clinical-grade panels), cost efficiency via automation (e.g., 23andMe’s saliva-based kits), and localized marketing. A key challenge is rising compliance costs due to evolving data protection laws, such as GDPR and HIPAA, which disproportionately impact smaller firms reliant on cross-border data flows.

23andMe expands digital health partnerships to enhance data analytics offerings.

Ancestry.com prioritizes international market expansion via localized content hubs.

MyHeritage focuses on AI-driven ancestry visualization tools to attract tech-savvy users.

LabCorp integrates consumer genetic tests with provider networks for healthcare adoption.

Quest Diagnostics optimizes costs through automation and OEM equipment tie-ups.

Myriad Genetics targets oncology-specific testing to capture high-margin clinical segments.

Key direct consumer genetic testing Companies29 items

23andMe

MyHeritage

Ancestry.com

LabCorp

Myriad Genetics

Quest Diagnostics

Gene By Gene

DNA Diagnostics Center

Invitae

IntelliGenetics

Ambry Genetics

Living DNA

EasyDNA

Pathway Genomics

Centrillion Technology

Xcode

Color Genomics

Anglia DNA Services

African Ancestry

Canadian DNA Services

DNA Family Check

Alpha Biolaboratories

Test Me DNA

23 Mofang

Genetic Health

DNA Services of America

Shuwen Health Sciences

Mapmygenome

Full Genomes

Market Ecosystem

The direct consumer genetic testing value chain analysis spans upstream technology inputs, midstream service integration, and downstream customer engagement. Value is generated through genetic data collection, bioinformatics analysis, and actionable insights delivered to individuals, with ecosystem participants varying by technical specialization and market access.

Genetic sequencing technology providers — supply hardware and software for DNA analysis and data generation

Sample collection kit manufacturers — produce saliva or swab collection tools for consumer use

Data analytics platforms — process raw genetic data into health, ancestry, or trait reports

Direct-to-consumer testing platforms — design, market, and distribute genetic tests via online portals

Third-party app developers — create complementary tools for data visualization or integration with health platforms

Healthcare providers — offer clinical interpretation or follow-up services for complex results

Regulators and standards bodies — enforce compliance with data privacy, testing accuracy, and ethical guidelines

Control points reside with testing platforms that manage customer acquisition and data flow, while dependency risks concentrate on sequencing technology suppliers and analytics vendors. Regulatory approvals and data interoperability standards act as bottlenecks, with consumer switching costs influenced by proprietary data ecosystems and privacy policies. Partnerships between platforms and healthcare systems may enhance clinical utility but introduce compliance complexities.

Recent Industry Insights

The direct consumer genetic testing industry trends have seen significant momentum over the past 18 months, driven by advancements in DNA sequencing, rising consumer interest in personalized health, and strategic industry moves. Companies have prioritized expanding their health risk assessments and ancestry insights, while regulatory frameworks have evolved to address data privacy and diagnostic accuracy.

Key Developments5 items

23andMe secured FDA authorization for a pharmacogenomics report, enabling users to understand drug responses based on genetic data.

Ancestry acquired MyHeritage for $450 million, strengthening its position in the genealogy segment and enhancing cross-platform data integration.

Startups like Color Genomics partnered with employers to offer affordable genetic screening programs, reflecting a shift toward enterprise wellness solutions.

Regulatory updates, including the EU’s General Data Protection Regulation (GDPR) revisions, have pressured firms to enhance data encryption and user consent protocols.

AI-powered analytics now dominate new product launches, with firms like Helix deploying machine learning to predict complex traits and disease risks.

Funding remains robust, with Series B rounds totaling over $200 million for companies leveraging CRISPR-based diagnostics and blockchain for secure data sharing. As consumer demand shifts toward preventive healthcare, the direct consumer genetic testing industry trends will likely see deeper integration with telemedicine and precision medicine platforms.

Analyst Overview

The direct consumer genetic testing market outlook remains robust, driven by growing health awareness, advancements in genomic sequencing, and demand for personalized insights. Market attractiveness is underscored by expanding applications in ancestry, wellness, and disease risk assessment, with emerging economies offering untapped potential. However, competitive intensity is escalating, as established players like 23andMe and AncestryDNA face challenges from agile startups leveraging AI-driven analytics and niche offerings. While the long-term outlook is optimistic, innovation hinges on addressing data privacy concerns and integrating multi-omics technologies to enhance predictive accuracy. Current demand-supply dynamics reflect a slight imbalance, with rising consumer expectations outpacing scalability in sample processing and result interpretation. Key risks include regulatory scrutiny, data security vulnerabilities, and ethical debates over genetic information usage. Strategic partnerships and investments in telehealth integration could redefine the landscape, but stakeholders must prioritize transparency to sustain trust and growth.

11 items

1. Executive Summary

2. direct consumer genetic testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global direct consumer genetic testing Market Outlook & Forecast (2021-2033) Value (USD Million)

7. Global direct consumer genetic testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global direct consumer genetic testing Market by: Regions (Value)

8. Global direct consumer genetic testing Market Competition by Key Manufacturers

8.1. Global direct consumer genetic testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global direct consumer genetic testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 23andMe

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. MyHeritage

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Ancestry.com

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. LabCorp

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Myriad Genetics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Quest Diagnostics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Gene By Gene

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. DNA Diagnostics Center

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Invitae

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. IntelliGenetics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Ambry Genetics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Living DNA

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. EasyDNA

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Pathway Genomics

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Centrillion Technology

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Xcode

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Color Genomics

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Anglia DNA Services

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. African Ancestry

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Canadian DNA Services

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. DNA Family Check

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Alpha Biolaboratories

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Test Me DNA

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. 23 Mofang

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Genetic Health

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. DNA Services of America

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Shuwen Health Sciences

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Mapmygenome

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Full Genomes

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

16 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global direct consumer genetic testing Market

Figure 4: Global direct consumer genetic testing Market: Drivers

Figure 5: Global direct consumer genetic testing Market: Challenges

Figure 6: Global direct consumer genetic testing Market: Trends

Figure 7: Global direct consumer genetic testing Market: Opportunity

Figure 8: Global direct consumer genetic testing Market: Restraint

Figure 9: Global direct consumer genetic testing Market: Porter's Five Forces

Figure 10: Global direct consumer genetic testing Market Value (USD Million) By Region

Figure 11: Global direct consumer genetic testing Market Share (%) By: Regions (2024)

Figure 12: Top 5 Manufacturers

Figure 13: Top 3 Manufacturers

Figure 14: Global direct consumer genetic testing Market Value (USD Million) By Region

Figure 15: Global direct consumer genetic testing Market Share (%) By: Regions (2032)

Figure 16: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global direct consumer genetic testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 3: Global direct consumer genetic testing Market Value (USD Million) By Region

Table 4: Global direct consumer genetic testing Market Share (%) By Region

Table 5: North America Market Value (USD Million) (2020-2024) By Country

Table 6: Europe Market Value (USD Million) (2020-2024) By Country

Table 7: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 8: South America Market Value (USD Million) (2020-2024) By Country

Table 9: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 10: Global direct consumer genetic testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 11: Global direct consumer genetic testing Market: Profiled Players Head Office And Area Served

Table 12: Key Players Global direct consumer genetic testing Market:

Table 13: Mergers & Acquisitions, Expansion Plans

Table 14: 23andMe Basic Information And Sales Area

Table 15: 23andMe. Products Portfolio

Table 16: MyHeritage Basic Information And Sales Area

Table 17: MyHeritage. Products Portfolio

Table 18: Ancestry.com Basic Information And Sales Area

Table 19: Ancestry.com. Products Portfolio

Table 20: LabCorp Basic Information And Sales Area

Table 21: LabCorp. Products Portfolio

Table 22: Myriad Genetics Basic Information And Sales Area

Table 23: Myriad Genetics. Products Portfolio

Table 24: Quest Diagnostics Basic Information And Sales Area

Table 25: Quest Diagnostics. Products Portfolio

Table 26: Gene By Gene Basic Information And Sales Area

Table 27: Gene By Gene. Products Portfolio

Table 28: DNA Diagnostics Center Basic Information And Sales Area

Table 29: DNA Diagnostics Center. Products Portfolio

Table 30: Invitae Basic Information And Sales Area

Table 31: Invitae. Products Portfolio

Table 32: IntelliGenetics Basic Information And Sales Area

Table 33: IntelliGenetics. Products Portfolio

Table 34: Ambry Genetics Basic Information And Sales Area

Table 35: Ambry Genetics. Products Portfolio

Table 36: Living DNA Basic Information And Sales Area

Table 37: Living DNA. Products Portfolio

Table 38: EasyDNA Basic Information And Sales Area

Table 39: EasyDNA. Products Portfolio

Table 40: Pathway Genomics Basic Information And Sales Area

Table 41: Pathway Genomics. Products Portfolio

Table 42: Centrillion Technology Basic Information And Sales Area

Table 43: Centrillion Technology. Products Portfolio

Table 44: Xcode Basic Information And Sales Area

Table 45: Xcode. Products Portfolio

Table 46: Color Genomics Basic Information And Sales Area

Table 47: Color Genomics. Products Portfolio

Table 48: Anglia DNA Services Basic Information And Sales Area

Table 49: Anglia DNA Services. Products Portfolio

Table 50: African Ancestry Basic Information And Sales Area

Table 51: African Ancestry. Products Portfolio

Table 52: Canadian DNA Services Basic Information And Sales Area

Table 53: Canadian DNA Services. Products Portfolio

Table 54: DNA Family Check Basic Information And Sales Area

Table 55: DNA Family Check. Products Portfolio

Table 56: Alpha Biolaboratories Basic Information And Sales Area

Table 57: Alpha Biolaboratories. Products Portfolio

Table 58: Test Me DNA Basic Information And Sales Area

Table 59: Test Me DNA. Products Portfolio

Table 60: 23 Mofang Basic Information And Sales Area

Table 61: 23 Mofang. Products Portfolio

Table 62: Genetic Health Basic Information And Sales Area

Table 63: Genetic Health. Products Portfolio

Table 64: DNA Services of America Basic Information And Sales Area

Table 65: DNA Services of America. Products Portfolio

Table 66: Shuwen Health Sciences Basic Information And Sales Area

Table 67: Shuwen Health Sciences. Products Portfolio

Table 68: Mapmygenome Basic Information And Sales Area

Table 69: Mapmygenome. Products Portfolio

Table 70: Full Genomes Basic Information And Sales Area

Table 71: Full Genomes. Products Portfolio

Table 72: Global direct consumer genetic testing Market Value (USD Million) By Region

Table 73: Global direct consumer genetic testing Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

direct consumer genetic testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	8.94 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	23andMe; MyHeritage; Ancestry.com; LabCorp; Myriad Genetics; Quest Diagnostics; Gene By Gene; DNA Diagnostics Center; Invitae; IntelliGenetics; Ambry Genetics; Living DNA; EasyDNA; Pathway Genomics; Centrillion Technology; Xcode; Color Genomics; Anglia DNA Services; African Ancestry; Canadian DNA Services; DNA Family Check; Alpha Biolaboratories; Test Me DNA; 23 Mofang; Genetic Health; DNA Services of America; Shuwen Health Sciences; Mapmygenome; Full Genomes
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options